The global clinical trial supplies market was valued at approximately USD 2.58 billion in 2023 and is forecasted to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. This growth is attributed to the increasing globalization of clinical trials and a rise in the number of biologics and biosimilar drugs being tested. The biopharmaceutical industry is also experiencing greater...